Categories: News

Akoya to Participate at Two Upcoming Investor Conferences

MARLBOROUGH, Mass., July 27, 2022 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be participating in two upcoming investor conferences.

  • UBS Genomics 2.0 and MedTech Innovation Conference
    Fireside Chat – Brian McKelligon, Chief Executive Officer, and Niro Ramachandran, Chief Business Officer, will participate in a fireside chat on Tuesday, August 9th at 1:00 PM PT.
  • Canaccord Growth Conference
    Panel: The New Frontier of Life Sciences: Spatial Omics is Transforming Biological AnalysisBrian McKelligon, Chief Executive Officer, will participate in a panel discussion on Wednesday, August 10th at 12:00 PM ET. Canaccord Genuity has arranged for all presentations to be broadcasted live and available for replay via the conference portal for 14 days.

About Akoya Biosciences
As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com.

Investor Contact:
Priyam Shah
Sr. Director, Investor Relations
Akoya Biosciences, Inc.
investors@akoyabio.com

Media Contact:
Christine Quern
(617) 650-8497
media@akoyabio.com

Staff

Recent Posts

Neural Therapeutics Undertakes Multiple Initiatives to Defer and Eliminate a Significant Portion of Financial Obligations

Toronto, Ontario--(Newsfile Corp. - November 25, 2024) - Neural Therapeutics Inc. ("Neural" or the "Company"),…

46 minutes ago

Psyched Wellness Announces Appointment of New Director and Resignation of a Director

Toronto, Ontario--(Newsfile Corp. - November 25, 2024) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF)…

46 minutes ago

Delivra Health Brands and its Leading Brands Dream Water (R) and LivRelief(TM) Report Financial Results for First Quarter of Fiscal 2025

Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - Delivra Health Brands Inc. (TSXV: DHB)…

46 minutes ago

BioGene Therapeutics Welcomes Dr. Deepak Sampath, PhD. to Its Board of Directors

Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB:…

2 hours ago

Edison Issues Report on Care REIT (CRT)

London, United Kingdom--(Newsfile Corp. - November 25, 2024) - Edison issues report on Care REIT…

3 hours ago

Hisense Launches End-of-Year Sale in UAE with Up to 55% Discounts

DUBAI, UAE, Nov. 25, 2024 /PRNewswire/ -- Hisense, a global leader in consumer electronics and…

3 hours ago